Nighttime Sleep-aid Liquid
NDC Package 76281-522-24
Package Information
Nighttime Sleep-aid (diphenhydramine hci) liquids is ■ take only as recommended■ Use dosage cup or tablespoon Age DoseAdults & children 12 One Dose = 2 tablespoons (30 mL) at bedyears & over time if needed or as directed by a doctor. This formulation utilizes a liquid delivery system. Marketed by Aptapharma Inc., this product is identified by NDC 76281-522 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1248354 - diphenhydrAMINE HCl 50 MG in 30 mL Oral Solution
- RxCUI: 1248354 - diphenhydramine hydrochloride 1.67 MG/ML Oral Solution
- RxCUI: 1248354 - diphenhydramine HCl 1.667 MG/ML Oral Solution
- RxCUI: 1248354 - diphenhydramine HCl 50 MG per 30 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 76281 - Aptapharma Inc.
- 76281-522 - Nighttime Sleep-aid
- 76281-522-24 - 118 mL in 1 BOTTLE
- 76281-522 - Nighttime Sleep-aid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (76281-522). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 76281-522-24 identifies a specific commercial package of 118 ml in 1 bottle of Nighttime Sleep-aid Non-habit Forming, a human over the counter drug labeled by Aptapharma Inc.. This liquid is formulated for oral use and contains diphenhydramine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aptapharma Inc. on January 01, 2018. The current certification is valid through December 31, 2026.
How is this Aptapharma Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 76281052224. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.